VIR-576
VIR-576[edit | edit source]
VIR-576 is a peptide-based entry inhibitor that targets the HIV-1 virus, specifically designed to prevent the virus from entering host cells. It is derived from the naturally occurring peptide VIRIP, which is found in human blood.
Mechanism of Action[edit | edit source]
VIR-576 functions by binding to the gp41 subunit of the HIV envelope glycoprotein. This binding inhibits the conformational changes necessary for the fusion of the viral and cellular membranes, thereby blocking the entry of the virus into the host cell. The peptide mimics a region of the gp41 protein, interfering with the fusion process.
Development and Research[edit | edit source]
The development of VIR-576 was based on the discovery of the VIRIP peptide, which was identified as a natural inhibitor of HIV-1. Researchers modified VIRIP to enhance its antiviral activity, resulting in the creation of VIR-576. Clinical trials have demonstrated its potential efficacy in reducing viral load in patients with HIV.
Clinical Trials[edit | edit source]
Initial clinical trials of VIR-576 have shown promising results, with a significant reduction in viral load observed in patients. The trials focused on the safety and efficacy of the peptide, and further studies are ongoing to optimize its use in combination with other antiretroviral therapies.
Advantages and Challenges[edit | edit source]
One of the main advantages of VIR-576 is its novel mechanism of action, which differs from other antiretroviral drugs. This makes it a valuable addition to the existing arsenal of HIV treatments, particularly for patients with drug-resistant strains of the virus. However, challenges remain in terms of delivery and stability of the peptide in the human body.
Related Pages[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
VIR-576 3D Structure
Estructura VIRIP
Estructura VIR-576
VIRIP Secondary Structure
VIR-576 Secondary Structure
HIV Attachment
HIV-1 MARAV
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
